Werbung
Werbung

RBOT

RBOT logo

Vicarious Surgical Inc.

2.63
USD
Gesponsert
+0.06
+2.49%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

2.62

-0.01
-0.53%

RBOT Ergebnisberichte

Positives Überraschungsverhältnis

RBOT übertreffen die 9 der letzten 17Schätzungen.

53%

Nächster Bericht

Datum des nächsten Berichts
16. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$1.39
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
-25.27%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
-41.10%

Vicarious Surgical Inc. earnings per share and revenue

On 12. Nov. 2025, RBOT reported earnings of -1.86 USD per share (EPS) for Q3 25, beating the estimate of -2.37 USD, resulting in a 21.62% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -15.53% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -1.39 USD, with revenue projected to reach -- USD, implying an decrease of -25.27% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06. Jan. 2026 For Q2 26
Estimate
-$0.10
Aktuell
$0.00
Überraschung
+100.00%
FAQ
For Q3 2025, Vicarious Surgical Inc. reported EPS of -$1.86, beating estimates by 21.62%, and revenue of $0.00, 0% as expectations.
The stock price moved down -15.53%, changed from $4.12 before the earnings release to $3.48 the day after.
The next earning report is scheduled for 16. März 2026.
Based on 3 analysts, Vicarious Surgical Inc. is expected to report EPS of -$1.39 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung